稳健医疗：2026年医疗板块将以“决胜增长”为核心目标

Core Viewpoint - The company aims for "decisive growth" in its medical sector by 2026, emphasizing "product leadership" as the foundation of its strategy [2] Group 1: Strategic Focus - The core strategy revolves around "product leadership, operational excellence, brand enhancement, and digital intelligence empowerment" [2] - The company plans to execute three key battles: focusing on strategic product breakthroughs, enhancing its omnichannel layout domestically and internationally, and integrating newly acquired companies [2] Group 2: Growth Drivers - Growth in the medical sector will be driven by both organic and external acquisitions [2] - On the organic side, the company will optimize its product structure and promote high-margin, high-growth categories while expanding into overseas markets and various domestic channels [2] - The acquisition of the U.S. company GRI in 2024 has provided valuable overseas channel resources, customer resources, and production capacity, facilitating smooth integration and supply chain transitions [2] Group 3: Future Goals - By 2026, the company will focus on transforming its products into high-value offerings and its business model into a brand-oriented approach, while continuously expanding its overseas market presence [2] - The company aims to achieve revenue growth targets set by equity incentives and further enhance profit margins [2]